ASTERIX: An observational study to identify sub-groups of COVID-19 patients based on their demographic, clinical and laboratory profile, and to determine if these sub-groups can be used to predict severity of disease and response to therapy
Not Applicable
Completed
- Conditions
- COVID-19 (SARS-CoV-2 infection)Infections and Infestations
- Registration Number
- ISRCTN66141262
- Lead Sponsor
- HS Greater Glasgow and Clyde
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 6000
Inclusion Criteria
1. Admitted to hospital with suspected COVID-19
Exclusion Criteria
1. Aged <8 years (lower age limit aligns with current NHSGGC Biorepository REC approval for storage and use of surplus tissue)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To acquire and record the necessary biological and outcome data by extracting electronic medical records held by the NHS trust Safe Haven, collected at various timepoints by automated processes. Daily clinical data (e.g. oxygen requirement, clinical observations, vital status) will also be collected by ward staff using a bedside clinical collection tool embedded in clinical care daily clinical data (the NHSGGC COVID19 assessment tool). Biological materials (e.g. blood, respiratory secretions, urine) for potential translational research will be surplus material from that routinely collected during the hospital admission, and also any follow-up hospital visits within 1 year.
- Secondary Outcome Measures
Name Time Method There are no secondary outcome measures